Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,110.1
38.9 (1.27%)

 

  • STI Straits Times Index
    3,110.1
    38.9 (1.27%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,622.3
    10.5 (0.65%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,983.8
    443.0 (1.55%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,415.2
    -6.2 (-0.18%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,004.5
    261.3 (0.91%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,246.9
    -1.6 (-0.02%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 921.6M
  • Value: 998.4M
  • Rise: 161
  • Fall: 112
  • Unch: 502

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.038-0.005
Sembcorp Marine0.161+0.001
CWX Global0.006+0.001
Jiutian Chemical0.082+0.002
Shen Yao0.004-
FJ Benjamin0.046+0.002
3Cnergy0.020+0.002
Enviro-Hub0.076+0.003
ComfortDelGro1.700+0.060
YZJ Shipbldg SGD1.100-0.010

World Indices

World Indices
Name Last Change
Nasdaq 12,609.2 -311.0
HSI 28,967.2 +426.4
HSCEI 11,107.8 +93.0
Jakarta 6,239.8 -8.7
Nikkei 225 29,009.1 +265.9
SSE Comp 3,415.2 -6.2
Shanghai A 3,579.8 -6.5
Shanghai B 242.1 +0.9
KOSPI 2,976.3 -19.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ZENTALIS PHARMACEUTICALS INC ZENTALIS PHARMACEUTICALS INC
Updated on 08 Mar 2021 (End of trading day)
Last (USD): 39.370 Change: -2.960 High: 44.110 Remarks: -
Change (%): -6.99 Low: 39.115
Open 42.040 Yesterday's Close 42.33
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 258,167 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.12432 Trailing EPS (USD) e -1.12432 NAV (USD) b 8.3975
PE a - Trailing PE f - Price / NAV b 4.6883
Dividend (USD) d - Cash In Hand (USD) g 2.2788 Issued & Paid-up Shares c 40,613,900
Dividend Yield (%) d - Price / Cash In Hand g 17.277 Treasury Shares h -
Market Cap (M) 1,598.969 Enterprise Value (M) 1,257.182
Piotroski F Score 3 Exchange Code ZNTL Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 86.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 Nov 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 Apr 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ZENTALIS PHARMACEUTICALS INC NASDAQ 1,598.969 - - 4.6883 -
Industry Biotechnology NASDAQ 2,884.368 1438.131 - 6.8403 0.618
Local Peer AMGEN INC NASDAQ 131,575.310 18.113 18.113 13.9840 2.813
Local Peer GILEAD SCIENCES INC NASDAQ 81,364.202 661.524 661.498 4.4701 4.192
Local Peer ILLUMINA INC NASDAQ 55,970.158 85.320 85.320 11.9238 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 55,522.257 20.475 20.475 6.3915 -
Local Peer MODERNA INC NASDAQ 49,359.602 - - 19.2708 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 49,622.457 14.125 14.125 4.5008 -
Local Peer BIOGEN INC NASDAQ 41,132.243 10.282 10.282 3.8440 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 32,990.391 54.674 54.674 2.8315 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 26,957.682 - - 6.9672 -
Local Peer SEAGEN INC NASDAQ 26,935.464 43.892 43.892 7.7221 -
Local Peer 10X GENOMICS INC NASDAQ 24,249.928 - - 32.8116 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 21,504.640 - - 19.7679 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), BIO-TECHNE CORP (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), ARVINAS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), VERACYTE INC (NASDAQ), ALKERMES PLC (NASDAQ), NANTKWEST INC (NASDAQ), VIELA BIO INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ALLOVIR INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), PRECIGEN INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), REGENXBIO INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), OCUGEN INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), BIOATLA INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), NKARTA INC (NASDAQ), CYTOKINETICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALECTOR INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), VAXCYTE INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OMEROS CORP (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PASSAGE BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), INHIBRX INC (NASDAQ), EPIZYME INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERUS B V (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CHIMERIX INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), KADMON HLDGS INC (NASDAQ), HUMANIGEN INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), COMPUGEN (NASDAQ), ATRECA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AFFIMED N V (NASDAQ), AGENUS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ARDELYX INC (NASDAQ), AKOUOS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), XBIOTECH INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ALTIMMUNE INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVROBIO INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ADICET BIO INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), SESEN BIO INC (NASDAQ), VERASTEM INC (NASDAQ), ATHERSYS INC (NASDAQ), ONCORUS INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), IMMUNOME INC (NASDAQ), NEXTCURE INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), MEDICINOVA INC (NASDAQ), CABALETTA BIO INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), METACRINE INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), IMV INC (NASDAQ), INMUNE BIO INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ORGENESIS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), EVOGENE LTD (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), CONTRAFECT CORP (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LONGEVERON INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ARAVIVE INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), SYNLOGIC INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), INFLARX N V (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), SAVARA INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), COHBAR INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIOCARDIA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), SOLIGENIX INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), PRECIPIO INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), HISTOGEN INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer CSL LTD ASX 111,959.520 35.698 29.418 10.5949 1.193
Global Peer WUXI BIO HKEx 362,283.407 315.144 251.602 24.2524 -
Global Peer BEIGENE HKEx 208,958.732 - - 6.9649 -
Global Peer SINO BIOPHARM HKEx 152,015.771 49.528 59.404 4.2178 0.660
Global Peer ZAI LAB-SB HKEx 86,835.873 - - 9.5772 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,596.059 15.064 15.064 3.1763 -
Global Peer JOINN HKEx 34,659.814 162.728 142.025 31.3810 0.179
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer GENSCRIPT BIO HKEx 26,468.868 - - 3.6202 -
Global Peer ARCUS BIOSCIENCES INC NYSE 2,231.892 - - 4.4433 -
Other Global Peers 3SBIO (HKEx), NUVATION BIO INC (NYSE), MYOVANT SCIENCES LTD (NYSE), VIVA BIOTECH (HKEx), JACOBIO-B (HKEx), JW THERAP-B (HKEx), ALPHAMAB-B (HKEx), POLYNOVO LIMITED (ASX), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), JHBP-B (HKEx), MESOBLAST LTD (ASX), ASCENTAGE-B (HKEx), KINTOR PHARMA-B (HKEx), TELIX PHARMACEUTIC (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), SINOMAB BIO-B (HKEx), DPHARMA (Bursa), LEE'S PHARM (HKEx), ESSEX BIO-TECH (HKEx), ASCLETIS-B (HKEx), OPTHEA LIMITED (ASX), SQZ BIOTECHNOLOGIES CO (NYSE), IMUGENE LIMITED (ASX), NANOVIRICIDES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), ANTEOTECH LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), BIONOMICS LTD (ASX), NEXT SCIENCE LTD (ASX), CEL-SCI CORP (NYSE American), BIOMX INC (NYSE American), IMMUTEP LTD (ASX), ENZO BIOCHEM INC (NYSE), IBIO INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), LEAF RESOURCES LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), REGENT PACIFIC (HKEx), GENETIC TECHNOLOGIES (ASX), MEMPHASYS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), PATRYS LIMITED (ASX), Suntar Eco-City (SGX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --2.360
-5.66 %
10 Days -+2.890
+7.92 %
20 Days --1.150
-2.84 %
Medium Term Return 3 Months --14.440
-26.84 %
6 Months -+12.340
+45.65 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 22.000 - 61.290 Change From 1 Year Low +17.370 % Change From 1 Year Low (%) +78.95
Change From 1 Year High -21.920 % Change From 1 Year High (%) -35.76
2 Years Range 22.000 - 61.290 Change From 2 Years Low +17.370 % Change From 2 Years Low (%) +78.95
Change From 2 Years High -21.920 % Change From 2 Years High (%) -35.76
5 Years Range 22.000 - 61.290 Change From 5 Years Low +17.370 % Change From 5 Years Low (%) +78.95
Change From 5 Years High -21.920 % Change From 5 Years High (%) -35.76
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. Its lead product candidate, ZN-c5, is an oral selective estrogen receptor degrader (SERD) for the treatment of estrogen receptor positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer. The company was founded by Kevin D. Bunker on December 23, 2014 and is headquartered in New York, NY.

Historical Price Data

Date Open High Low Close Volume VWAP
08 Mar 2021 42.040 44.110 39.115 39.370 258,167 -
05 Mar 2021 44.090 44.145 38.800 42.330 481,759 -
04 Mar 2021 43.010 44.540 41.900 43.550 300,698 -
03 Mar 2021 43.550 45.510 42.280 43.630 337,553 -
02 Mar 2021 41.710 44.110 40.985 43.500 217,960 -
01 Mar 2021 42.450 42.470 40.530 41.730 284,464 -
26 Feb 2021 40.440 42.220 39.800 42.040 249,703 -
25 Feb 2021 39.650 42.290 39.570 40.410 326,335 -
24 Feb 2021 36.840 40.290 35.680 40.260 270,457 -
23 Feb 2021 35.930 36.900 34.480 36.130 224,405 -
22 Feb 2021 38.320 38.500 36.215 36.480 219,198 -
19 Feb 2021 35.810 38.430 35.810 38.320 229,809 -
18 Feb 2021 37.000 37.000 34.810 35.690 249,611 -
17 Feb 2021 37.240 38.170 35.040 37.310 440,898 -
16 Feb 2021 37.470 38.680 35.800 37.680 287,025 -
12 Feb 2021 38.160 38.595 35.770 36.450 161,517 -
11 Feb 2021 40.140 40.525 37.040 38.760 180,928 -
10 Feb 2021 39.040 41.210 39.040 39.850 193,119 -
09 Feb 2021 40.480 40.950 38.520 39.470 231,100 -
08 Feb 2021 41.290 42.260 40.450 40.520 149,140 -
05 Feb 2021 40.700 42.480 40.300 40.820 182,264 -
04 Feb 2021 41.210 42.252 39.520 40.250 162,259 -
Summary
Current 2 Weeks
(23 Feb 2021 to 08 Mar 2021)
35.930 45.510 34.480 39.370 2,951,501 -
Previous 2 Weeks
(08 Feb 2021 to 22 Feb 2021)
41.290 45.510 34.480 36.480 2,342,345 -
4 Weeks from
(08 Jan 2021 to 05 Feb 2021)
49.390 51.160 34.480 40.820 4,985,720 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.